Based on the Lifevantage Corporation stock forecast from 2 analysts, the average analyst target price for Lifevantage Corporation is USD 29.25 over the next 12 months. Lifevantage Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Lifevantage Corporation is Neutral, which is based on 7 positive signals and 8 negative signals. At the last closing, Lifevantage Corporation’s stock price was USD 14.18. Lifevantage Corporation’s stock price has changed by -2.74% over the past week, -7.92% over the past month and +131.70% over the last year.
Past 12 monthsNext 12 months
No recent analyst target price found for Lifevantage Corporation
No recent average analyst rating found for Lifevantage Corporation
Company Overview Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company also launch Evolve Compensation Plan and other LV360 initiatives into the Philippines, Taiwan, Hong Kong, and Singapore. The company is based in L Read Less
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary suppl...Read More
Frequently Asked Questions About Lifevantage Corporation (LFVN) Stock
Based on ratings from 2 analysts Lifevantage Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 4 buy, sell and hold ratings.
LFVN stock's dividend yield is 0.98%.
Our analysis grades LFVN stock's dividend yield at F. This means that LFVN stock's dividend yield is above 20% of the stocks in the Packaged Foods sector in the NSD exchange.
Based on this LFVN may be a poor dividend stock for its sector.
Based on targets from 2 analysts, the average taret price for LFVN is USD 29.25 over the next 12 months. The maximum analyst target price is USD 35 while the minimum anlayst target price is USD 26.
LFVN stock's Price/Earning ratio is 28.63.
Our analysis grades LFVN stock's Price / Earning ratio at F. This means that LFVN stock's Price/Earning ratio is above 60% of the stocks in the Packaged Foods sector in the NSD exchange.
Based on this LFVN may be a overvalued for its sector.
The last closing price of LFVN's stock was USD 14.18.
The most recent market capitalization for LFVN is USD 0.20B.
Based on targets from 2 analysts, the average taret price for LFVN is projected at USD 29.25 over the next 12 months.
This means that LFVN's stock price may go up by +111.04% over the next 12 months.
We can't find any ETFs which contains Lifevantage Corporation's stock.
As per our most recent records Lifevantage Corporation has 222 Employees.
Lifevantage Corporation's registered address is 3300 North Triumph Boulevard, Lehi, UT, United States, 84043.
You can get more information about it from Lifevantage Corporation's website at https://www.lifevantage.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Lifevantage Corporation (LFVN) Stock
Based on ratings from 2 analysts Lifevantage Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 4 buy, sell and hold ratings.
LFVN stock's dividend yield is 0.98%.
Our analysis grades LFVN stock's dividend yield at F. This means that LFVN stock's dividend yield is above 20% of the stocks in the Packaged Foods sector in the NSD exchange.
Based on this LFVN may be a poor dividend stock for its sector.
Based on targets from 2 analysts, the average taret price for LFVN is USD 29.25 over the next 12 months. The maximum analyst target price is USD 35 while the minimum anlayst target price is USD 26.
LFVN stock's Price/Earning ratio is 28.63.
Our analysis grades LFVN stock's Price / Earning ratio at F. This means that LFVN stock's Price/Earning ratio is above 60% of the stocks in the Packaged Foods sector in the NSD exchange.
Based on this LFVN may be a overvalued for its sector.
The last closing price of LFVN's stock was USD 14.18.
The most recent market capitalization for LFVN is USD 0.20B.
Based on targets from 2 analysts, the average taret price for LFVN is projected at USD 29.25 over the next 12 months.
This means that LFVN's stock price may go up by +111.04% over the next 12 months.
We can't find any ETFs which contains Lifevantage Corporation's stock.
As per our most recent records Lifevantage Corporation has 222 Employees.
Lifevantage Corporation's registered address is 3300 North Triumph Boulevard, Lehi, UT, United States, 84043.
You can get more information about it from Lifevantage Corporation's website at https://www.lifevantage.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LFVN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
